Écrit par Adocia | 26 Août 2015

· En parallèle de la formulation U100 à la concentration standard des produits d'insuline, Adocia a développé une formulation deux fois plus concentrée, U200, de BioChaperone Lispro.

· Cette étude clinique de phase I, réalisée sur des volontaires sains, est conçue pour évaluer le potentiel de bioéquivalence des formulations U100 et U200 de BioChaperone Lispro.

 

Lyon, France...

Écrit par WHO | 26 Août 2015

Sana’a, 23 August 2015: In response to the growing humanitarian crisis in Tiaz and Hodeida governorates, and the rising number of civilian injuries in the southern governorates of Yemen, WHO is coordinating a rapid response to provide emergency health access to the injured, internally displaced persons and host communities.

Thousands of people have been injured in Taiz since the start of...

Écrit par WHO | 24 Août 2015

GENEVA: 18 AUGUST 2015 - People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, one in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5 million children still die each year of diseases that could be prevented by vaccines that already exist...

Écrit par WHO | 14 Août 2015

14 AUGUST 2015 ¦ GENEVA – Ahead of World Humanitarian Day, WHO is drawing attention to continued attacks on health staff and health facilities. In 2014 alone, WHO received reports of 372 attacks in 32 countries on health workers, resulting in 603 deaths and 958 injuries, while similar incidents have been recorded this year.

“WHO is committed to saving lives and reducing suffering in...